A detailed history of Walleye Capital LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 108,374 shares of PRME stock, worth $363,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,374
Holding current value
$363,052
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.41 - $6.7 $369,555 - $726,105
108,374 New
108,374 $419,000
Q1 2024

May 15, 2024

SELL
$6.35 - $9.39 $367,430 - $543,333
-57,863 Reduced 84.71%
10,443 $73,000
Q4 2023

Feb 14, 2024

BUY
$5.59 - $9.55 $322,017 - $550,137
57,606 Added 538.37%
68,306 $605,000
Q3 2023

Nov 14, 2023

BUY
$9.5 - $15.07 $101,650 - $161,249
10,700 New
10,700 $102,000
Q4 2022

Feb 14, 2023

BUY
$15.2 - $21.12 $456,000 - $633,600
30,000 New
30,000 $557,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $321M
More about PRME
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.